TG THERAPEUTICS, INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$3
Book Value Per Share
$4
Free Cash Flow Per Share
$-0
Cash Per Share
$0
Revenue Per Share
$4
OCF Per Share
$-0
Return on Equity
102.8%
Return on Assets
54.5%
Return on Invested Capital
18.1%
Debt to Equity
0.38
Current Ratio
4.10
Quick Ratio
3.29
Asset Turnover
0.75
Days Sales Outstanding
181.01
Days Inventory On Hand
455.14
R&D / Revenue
26.0%
SBC / Revenue
10.5%
Capex / Revenue
0.0%
Working Capital
$477M
Net Current Asset Value
$216M
Invested Capital
$894M
OCF / Net Income
-0.06
FCF / Net Income
-0.06
Accruals Ratio (Sloan)
44.4%
Net Debt
$104M
Net Debt / EBITDA
0.84
Interest Coverage
4.61
Cash Coverage
-0.93
Capex Coverage
-115.76
Tangible Common Equity
$648M
TCE / Total Assets
60.9%
Goodwill / Total Assets
—
NOPAT
$123M
Cash ROIC
-3.7%
WC / Revenue
77.4%
Capex / D&A
3.63
Reinvestment Rate
0.1%
Total Payout Ratio
20.4%
Asset Growth vs Revenue Growth
-3.3%
Revenue 5Y CAGR
426.7%
Book Value 5Y CAGR
4.5%
Stock Price (FY-end)
$30
Market Cap
$4.81B
P/E Ratio
10.76
P/S Ratio
7.81
P/B Ratio
7.43
P/TB Ratio
7.43
Enterprise Value
$4.92B
EV / EBITDA
39.84
EV / Sales
7.98
FCF Yield
-0.5%
Shareholder Yield
0.6%
Buyback Yield
1.9%
R&D Yield
3.3%
Capex Yield
0.0%
Operating Leverage
2.22
Graham Number
$16
Shares Variation (YoY)
0.7%
Beta (5Y)
1.91
Cost of Equity
14.0%
Cost of Debt (after tax)
10.9%
52W High
$46
52W Low
$26
Trailing Return 1Y
-8.4%
Trailing Return 5Y
-45.0%
F-Score (Piotroski)
4.00
Z-Score (Altman)
7.03
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.